- Estimated deadline
- No fixed deadline
- Expected posting
- Aug 14, 2024
- Award size
- Not listed
- Total program funding
- Not listed
- Expected awards
- 10
- Cost sharing
- Not required
- Funding type
- Grant
- Category
- Consumer protection, Agriculture, Food and nutrition
Check this solicitation free
Grantee reads the full announcement and lists every required section, page limit, deadline, scoring criterion and compliance item. Takes about two minutes, no account needed.
About this opportunity
The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to address critical knowledge gaps, exert a significant impact on rare neurodegenerative diseases, and to inform current or future product development.
Who can apply
- Anyone (unrestricted)
- State governments
- Independent school districts
- Private universities
- City or township governments
- Nonprofits with 501(c)(3) status
- Public and Indian housing authorities
- Nonprofits without 501(c)(3) status
- Other Native American tribal organizations
- Public and state universities
- County governments
- Small businesses
- Special district governments
- For-profit organizations
- Federally recognized tribal governments
See the official notice for eligibility details.
Agency contact
Terrin Brown
Grantor
2404027610
- Reads the full solicitation and lays out every required section
- Drafts each section with you, in your words
- Checks the draft against every requirement before you submit
How to write it
All guidesMore from FDA
All FDA funding- OpenPAR-24-216
Minor Use Minor Species Development of Drugs (R01)
Deadline Jan 29, 2027Up to $250K
- OpenPAR-25-003
Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
Deadline Apr 1, 2027Up to $300K
- OpenPAR-25-014
NARMS Cooperative Agreement Program to Strengthen Antibiotic Resistance Surveillance in Retail Food Specimens
Deadline Apr 1, 2027Up to $200K
- OpenRFA-FD-25-007
Laboratory Flexible Funding Model (LFFM)
Deadline Jan 11, 2028Up to $1.5M
- OpenRFA-FD-25-017
Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Deadline Feb 8, 2028Up to $600K
- OpenPAR-24-251
Animal and Veterinary Innovation Centers (U18)
Deadline May 12, 2028Up to $1.3M
Get new funding every Monday
New federal opportunities and upcoming deadlines for FDA and more, in one short email. Free, unsubscribe anytime.
Details from Grants.gov, last updated Mar 26, 2026. Deadlines and requirements can change: always confirm them in the official notice.